arrow
M

Marco Herling

Leipzig University Medical Center
H指数:44
被引数:6,861

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Creating a palliative care skills training for health care professionals in allogeneic haematopoietic stem cell transplantation recipients: symptom management to end-of-life care

为异基因造血干细胞移植受者创建姑息治疗技能培训:从症状管理到临终关怀

2026-11-130
OA
Goals-of-care transition after an allogeneic hematopoietic stem-cell transplantation: A cross-sectional survey among hematologists on associated challenges

异基因造血干细胞移植后的治疗目标转变:针对血液科医生相关挑战的横断面调查

2026-04-270
OAAI
How to talk about death? A cross-sectional survey on patients’, informal caregivers’ and health care professionals’ views in the setting of allogenic hematopoietic stem cell transplantation

如何谈论死亡?一项关于异基因造血干细胞移植背景下患者、非正式护理人员和医疗保健专业人员观点的横断面调查

2026-04-020
OAAI
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

MyCARdiac评分:整合心脏成像和生物标志物以预测接受cilta-cel治疗的RRMM患者的结局

Leukemia
IF13.4
2026-02-170
OAAI
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation

12 Gy全身照射和环磷酰胺的顺序不会影响接受骨髓 ablative 异基因干细胞移植的AML患者的结局

2025-12-020
OAAI
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts

健康与疾病中的组织驻留髓系和组织细胞:新兴概念

2025-09-120
PREAI
Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program

tagraxofusp治疗初治性暴发性浆样树突状细胞肿瘤患者的持久疗效与可控安全性,可延长患者生存期:欧洲指定患者项目真实世界研究结果

2025-08-020
OA
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells

单核细胞浓缩物中细胞组成和T细胞衰老对嵌合抗原受体(CAR)T细胞制备过程的影响

2025-07-290
OA
Prognostic implications of splenomegaly in BCMA-directed CAR T-Cell therapy for relapsed myeloma

脾肿大在BCMA靶向CAR T细胞疗法治疗复发多发性骨髓瘤中的预后意义

2025-07-160
OAAI
Impact of Evolving WHO and ICC Classifications on Prognosis and Outcomes in AML Patients Undergoing Allogeneic Stem Cell Transplantation

世界卫生组织(WHO)和欧洲血液和骨髓移植学会(EBMT)分类的演变对接受异基因造血干细胞移植的急性髓系白血病(AML)患者预后和结局的影响

2025-04-080
PRE
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma

双重特异性STAT3/5降解剂有效阻断急性髓系白血病和自然杀伤/T细胞淋巴瘤

2024-11-280
OAAI